Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Mature B-Cell Malignancies × zanubrutinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Lymphocytic, Chronic, B-Cell 3 Recurrence 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia 2 Mature B-Cell Malignancies 1 Lymphoma, B-Cell 1 B-cell Malignancies 1

Interventions

zanubrutinib 1 obinutuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04277637 2025-02-17

Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies

BeiGene

Phase 1 Active not recruiting

Mature B-Cell Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡